Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
Insightful Analysis of Eli Lilly's Market Position and Future Prospects
Source: yahoo.com
Page 2 - Generic Competition News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Generic Competition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Generic Competition Today - Breaking & Trending Today
Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...
Full Year 2023 Revenue Drops by 24% as Company Navigates Commercial and Regulatory Hurdles
Source: yahoo.com
Bristol Myers plans to double experimental treatments to expand research pipeline
The drugmaker, which currently has six candidates in trials, will advance six more in its research pipeline - including three cell therapies that target immune system disorders and different types of cancer. The New York-based company has been pressured by declining demand for two of its top drugs, the blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. Bristol and partner Pfizer's blood thinner Eliquis was also on the list of 10 drugs that will be subject to the first-ever price negotiations by the U.S. Medicare health program.
Source: yahoo.com